Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
Home
About UsRefund & CancellationProduct / Service Details
Contact UsDelivery & Shipping PolicyPrivacy Policy
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine

Glimpure MV 2.3 Tablet

strip of 10.0 tablets
Prescription Required
30 minute delivery
strip of 10.0 tablets
₹ 129.00
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Manufacturer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Manufacturer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Key Information

Short Description

Glimpure MV 2.3 Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet

Introduction

Glimpure MV 2.3 Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Directions for Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimpure MV 2.3 Tablet is to be taken empty stomach.

Safety Information

Side Effects

No common side effects listed.

Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Glimpure MV 2.3 Tablet.

Breastfeeding Warning

Breastfeeding Warning

Glimpure MV 2.3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Pregnancy Warning

Pregnancy Warning

Glimpure MV 2.3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

How it works

Glimpure MV 2.3 Tablet is a combination of three antidiabetic medicines.

Quick Tips

Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Short Description

Glimpure MV 2.3 Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet

Introduction

Glimpure MV 2.3 Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimpure MV 2.3 Tablet is to be taken empty stomach.

Side Effects

No common side effects listed.
Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Glimpure MV 2.3 Tablet.
Breastfeeding Warning

Breastfeeding Warning

Glimpure MV 2.3 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning

Pregnancy Warning

Glimpure MV 2.3 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimpure MV 2.3 Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).

Related Medicines

medicine

Glimpure MV 2.3 Tablet

1 Strip of 15 Tablets
20% off1 Strip of 15 Tablets
₹ 255.00
20% off
medicine

Voglisoor GM 2mg/500mg/0.3mg Tablet

strip of 15.0 tablets
20% offstrip of 15.0 tablets
₹ 150.00
20% off
medicine

Metffil VG 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 117.00
20% off
medicine

Voglex GM 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 132.50
20% off
medicine

Voglow 0.3 GM2 Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 132.00
20% off
medicine

Glimet V 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 130.00
20% off
medicine

Trivoglizar 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 108.90
20% off
medicine

Giobose MV Forte 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 128.50
20% off
medicine

Trivobiwin Forte 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 134.00
20% off
medicine

Alphavog GM 2mg/500mg/0.3mg Tablet

strip of 10.0 tablets
20% offstrip of 10.0 tablets
₹ 140.00
20% off

Frequently asked questions

What is Glimpure MV 2.3 Tablet?

Glimpure MV 2.3 Tablet is a combination of Glimepiride, Metformin, and Voglibose, used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by reducing glucose production from the liver and enhancing insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not intended for treating type 1 diabetes.

What are possible side effects of Glimpure MV 2.3 Tablet?

Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.

Are there any specific conditions for which Glimpure MV 2.3 Tablet should not be taken?

Avoid using this medication if you have known allergies to any of its components or excipients. This medication is also contraindicated in individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis).

Is it safe to take alcohol while I am also taking Glimpure MV 2.3 Tablet?

No, combining Glimpure MV 2.3 Tablet with alcohol is not advised. It can lead to lowered blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.

Can Glimpure MV 2.3 Tablet cause hypoglycemia?

Yes, Glimpure MV 2.3 Tablet may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely when you miss meals, drink alcohol, over-exercise, take other antidiabetic medications, or delay food intake.

What are the instructions for storing and disposing of Glimpure MV 2.3 Tablet?

Store this medicine in its original packaging, tightly closed, according to the label instructions. Dispose of unused medication properly and ensure it is not accessible to pets, children, or others.

Glimpure MV 2.3 Tablet is a combination of Glimepiride, Metformin, and Voglibose, used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with proper diet and exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin works by reducing glucose production from the liver and enhancing insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not intended for treating type 1 diabetes.
Possible side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Avoid using this medication if you have known allergies to any of its components or excipients. This medication is also contraindicated in individuals with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis).
No, combining Glimpure MV 2.3 Tablet with alcohol is not advised. It can lead to lowered blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimpure MV 2.3 Tablet may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely when you miss meals, drink alcohol, over-exercise, take other antidiabetic medications, or delay food intake.
Store this medicine in its original packaging, tightly closed, according to the label instructions. Dispose of unused medication properly and ensure it is not accessible to pets, children, or others.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries